Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer
Read ReleaseMotus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF
Read ReleaseMotus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System
Read Release